CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,106 | +45.4% | 114 | +18.8% | 0.00% | – |
| Q2 2023 | $2,136 | -45.2% | 96 | -46.7% | 0.00% | – |
| Q1 2023 | $3,899 | +99.9% | 180 | +87.5% | 0.00% | – |
| Q4 2022 | $1,950 | -78.3% | 96 | -71.8% | 0.00% | -100.0% |
| Q3 2022 | $9,000 | +350.0% | 340 | +254.2% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 96 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 96 | -50.5% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | +33.3% | 194 | +27.6% | 0.00% | 0.0% |
| Q3 2021 | $3,000 | -57.1% | 152 | -51.6% | 0.00% | -50.0% |
| Q2 2021 | $7,000 | +16.7% | 314 | +33.1% | 0.00% | +100.0% |
| Q1 2021 | $6,000 | +20.0% | 236 | +33.3% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +150.0% | 177 | +84.4% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | +100.0% | 96 | +92.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |